Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023
China started to offer human papillomavirus (HPV) vaccines to females aged 9–45 years in 2016. However, there was a lack of reports about HPV vaccination coverage in a representative sample of females in China. Therefore, this study aimed to examine the current HPV coverage and associated factors am...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/12/1/75 |
| _version_ | 1797339318945054720 |
|---|---|
| author | Zian Lin Xue Liang Lixian Su Weijun Peng Hongbiao Chen Yuan Fang Siyu Chen Weikang Yang Wensheng Chen Lijun Zhang Zixin Wang |
| author_facet | Zian Lin Xue Liang Lixian Su Weijun Peng Hongbiao Chen Yuan Fang Siyu Chen Weikang Yang Wensheng Chen Lijun Zhang Zixin Wang |
| author_sort | Zian Lin |
| collection | DOAJ |
| description | China started to offer human papillomavirus (HPV) vaccines to females aged 9–45 years in 2016. However, there was a lack of reports about HPV vaccination coverage in a representative sample of females in China. Therefore, this study aimed to examine the current HPV coverage and associated factors among females aged 9–50 years in Shenzhen, China, based on administrative health records kept by community health centers. A multistage random sampling approach was used. The research team randomly selected 18 community health centers in Shenzhen, and 3118 health records of females aged 9–50 years were then randomly selected from these health centers. Among all participants, 18.7% received at least one dose of HPV vaccination. The highest coverage was observed among females aged 18–26 years (23.4%), followed by those aged 27–35 years (22.0%) and 36–45 years (20.2%). Such coverage was very low among females aged 9–17 years (4.6%) and those aged 46–50 years (3.2%). Among females aged 18 years or above, higher education level, having a family doctor, and permanent residency in Shenzhen were associated with higher HPV vaccination coverage, while older age and being married/divorced were negatively associated with coverage. The HPV vaccination coverage in Shenzhen was 18.7% and there is a strong need for improvement. |
| first_indexed | 2024-03-08T09:44:17Z |
| format | Article |
| id | doaj.art-07cf7fc6f9f84d9badb70eb5f6511936 |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-08T09:44:17Z |
| publishDate | 2024-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-07cf7fc6f9f84d9badb70eb5f65119362024-01-29T14:25:52ZengMDPI AGVaccines2076-393X2024-01-011217510.3390/vaccines12010075Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023Zian Lin0Xue Liang1Lixian Su2Weijun Peng3Hongbiao Chen4Yuan Fang5Siyu Chen6Weikang Yang7Wensheng Chen8Lijun Zhang9Zixin Wang10Shenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, ChinaCentre for Health Behavious Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR 999077, ChinaShenzhen Futian District Maternity and Child Healthcare Hospital, Shenzhen 518000, ChinaDepartment of Epidemiology and Infectious Disease Control, Longhua Key Discipline of Public Health for the Prevention and Control of Infectious Diseases, Longhua Centre for Disease Control and Prevention, Shenzhen 518000, ChinaDepartment of Epidemiology and Infectious Disease Control, Longhua Key Discipline of Public Health for the Prevention and Control of Infectious Diseases, Longhua Centre for Disease Control and Prevention, Shenzhen 518000, ChinaDepartment of Health and Physical Education, The Education University of Hong Kong, Hong Kong SAR 999077, ChinaCentre for Health Behavious Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR 999077, ChinaShenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, ChinaShenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, ChinaShenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, ChinaCentre for Health Behavious Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR 999077, ChinaChina started to offer human papillomavirus (HPV) vaccines to females aged 9–45 years in 2016. However, there was a lack of reports about HPV vaccination coverage in a representative sample of females in China. Therefore, this study aimed to examine the current HPV coverage and associated factors among females aged 9–50 years in Shenzhen, China, based on administrative health records kept by community health centers. A multistage random sampling approach was used. The research team randomly selected 18 community health centers in Shenzhen, and 3118 health records of females aged 9–50 years were then randomly selected from these health centers. Among all participants, 18.7% received at least one dose of HPV vaccination. The highest coverage was observed among females aged 18–26 years (23.4%), followed by those aged 27–35 years (22.0%) and 36–45 years (20.2%). Such coverage was very low among females aged 9–17 years (4.6%) and those aged 46–50 years (3.2%). Among females aged 18 years or above, higher education level, having a family doctor, and permanent residency in Shenzhen were associated with higher HPV vaccination coverage, while older age and being married/divorced were negatively associated with coverage. The HPV vaccination coverage in Shenzhen was 18.7% and there is a strong need for improvement.https://www.mdpi.com/2076-393X/12/1/75human papillomavirusHPVvaccinationvaccinesChina |
| spellingShingle | Zian Lin Xue Liang Lixian Su Weijun Peng Hongbiao Chen Yuan Fang Siyu Chen Weikang Yang Wensheng Chen Lijun Zhang Zixin Wang Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023 Vaccines human papillomavirus HPV vaccination vaccines China |
| title | Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023 |
| title_full | Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023 |
| title_fullStr | Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023 |
| title_full_unstemmed | Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023 |
| title_short | Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023 |
| title_sort | coverage with the first dose of human papillomavirus vaccination among females aged 9 50 years in shenzhen china a surveillance based on administrative health records in 2023 |
| topic | human papillomavirus HPV vaccination vaccines China |
| url | https://www.mdpi.com/2076-393X/12/1/75 |
| work_keys_str_mv | AT zianlin coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT xueliang coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT lixiansu coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT weijunpeng coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT hongbiaochen coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT yuanfang coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT siyuchen coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT weikangyang coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT wenshengchen coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT lijunzhang coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 AT zixinwang coveragewiththefirstdoseofhumanpapillomavirusvaccinationamongfemalesaged950yearsinshenzhenchinaasurveillancebasedonadministrativehealthrecordsin2023 |